Share on StockTwits

Covidien plc (NYSE:COV) saw a large growth in short interest in the month of July. As of July 31st, there was short interest totalling 4,958,375 shares, a growth of 84.5% from the July 15th total of 2,686,967 shares, ARN reports. Approximately 1.1% of the company’s stock are sold short. Based on an average trading volume of 5,915,966 shares, the short-interest ratio is presently 0.8 days.

Several analysts have recently commented on the stock. Analysts at Citigroup Inc. reiterated a “buy” rating on shares of Covidien plc in a research note on Monday, July 28th. They now have a $101.00 price target on the stock, up previously from $81.00. Separately, analysts at Leerink Swann raised their price target on shares of Covidien plc from $93.00 to $95.00 in a research note on Monday, July 28th. They now have a “market perform” rating on the stock. Finally, analysts at RBC Capital raised their price target on shares of Covidien plc from $71.00 to $95.00 in a research note on Monday, July 28th. Eleven investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Covidien plc presently has a consensus rating of “Hold” and a consensus price target of $87.54.

Shares of Covidien plc (NYSE:COV) opened at 87.72 on Tuesday. Covidien plc has a one year low of $59.17 and a one year high of $92.68. The stock has a 50-day moving average of $88.21 and a 200-day moving average of $76.78. The company has a market cap of $39.628 billion and a P/E ratio of 26.28.

Covidien plc (NYSE:COV) last released its earnings data on Friday, July 25th. The company reported $1.04 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.00 by $0.04. The company had revenue of $2.69 billion for the quarter, compared to the consensus estimate of $2.69 billion. During the same quarter in the prior year, the company posted $0.91 earnings per share. The company’s quarterly revenue was up 4.3% on a year-over-year basis. Analysts expect that Covidien plc will post $4.01 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Tuesday, August 19th. Investors of record on Tuesday, July 29th will be paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 1.46%. The ex-dividend date is Friday, July 25th.

Covidien Public Limited Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.